Quantitative evaluation of common polymorphism (rs1801282) in the PPARγ2 gene and hypertension susceptibility

Gene

Volumn 502, Issue 2, 2012, Pages 159-162

  Wang, Yujun ^a   Liu, Chibo ^b  

^a The First Hospital of Jiaxing   (China)

^b TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Hypertension; Meta analysis; Polymorphism; PPAR 2

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2;

ARTICLE; ASIAN; CAUCASIAN; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RACE DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FAR EAST; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PPAR GAMMA;

EID: 84861347631     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.04.035     Document Type: Article

References (29)

1. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
2. Boccia S., De Feo E., Gallì P., Gianfagna F., Amore R., Ricciardi G. A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur. J. Epidemiol. 2010, 25:765-775.
3. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
4. Dong, G.Y., 2009. The relationship between peroxisome proliferator-activated receptor γ2 and its coactivator PGC-1α with Mongolian hypertension. Dissertation of master degree candidate of Inner Mongolia Medical College. 1-34(Article in Chinese).
5. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
6. Gao L., Wang L., Yun H., Su L., Su X. Association of the PPARgamma2 gene Pro12Ala variant with primary hypertension and metabolic lipid disorders in Han Chinese of Inner Mongolia. Genet. Mol. Res. 2010, 9:1312-1320.
7. Gouda H.N., Sagoo G.S., Harding A.H., Yates J., Sandhu M.S., Higgins J.P. The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am. J. Epidemiol. 2010, 171:645-655.
8. Gouni-Berthold I., et al. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2. J. Hypertens. 2005, 23:301-308.
9. Harrison M., Maresso K., Broeckel U. Genetic determinants of hypertension: an update. Curr. Hypertens. Rep. 2008, 10:488-495.
10. Horiki M., et al. Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases. Diabetes Res. Clin. Pract. 2004, 66:S63-S67.
11. Kim K., Lee S., Valentine R.J. Association of pro12Ala polymorphism in the peroxisome proliferative-activated receptor gamma2 gene with obesity and hypertension in Korean women. J. Nutr. Sci. Vitaminol. (Tokyo) 2007, 53:239-246.
12. Kurtz T.W., Spence M.A. Genetics of essential hypertension. Am. J. Med. 1993, 94:77-84.
13. Lehrke M., Lazar M.A. The many faces of PPARgamma. Cell 2005, 123:993-999.
14. Levy D., et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 2009, 41:677-687.
15. Lu Z., et al. Pro12Ala polymorphism in PPAR gamma 2 associated with essential hypertension in Chinese nonagenarians/centenarians. Exp. Gerontol. 2008, 43:1108-1113.
16. Lu Y.L., et al. Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis. World J. Gastroenterol. 2010, 16:2170-2175.
17. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
18. Newton-Cheh C., et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 2009, 41:666-676.
19. Pan H.J., Guo Y.Y., Wang K., Zhao L., He B.X. Additive effects of the variants in the β3-AR and PPARγ2 genes on essential hypertension in Xinjiang Kazakh population. J. Birth Health Hered. 2007, 15:19-21. (Article in Chinese).
20. Paracchini V., Pedotti P., Taioli E. Genetics of leptin and obesity: a HuGE review. Am. J. Epidemiol. 2005, 162:101-114.
21. Rodríguez-Esparragón F.J., Rodríguez-Pérez J.C., Macías-Reyes A., Alamo-Santana F. Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/bgene polymorphisms are associated with essential hypertension. J. Hypertens. 2003, 21:1649-1655.
22. Shen D., Ha D.W. Relationship between PPARγ2 gene Pro12Ala polymorphism and hypertension and blood lipids. Chin. J. Hypertens. 2004, 12:319-322. (Article in Chinese).
23. Tontonoz P., Hu E., Spiegelman B.M. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 1995, 5:571-576.
24. Wu Y., et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008, 118:2679-2686.
25. Xu W., et al. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects. Oncol. Rep. 2010, 24:579-585.
26. Yen C.J., et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem. Biophys. Res. Commun. 1997, 241:270-274.
27. Zafarmand M.H., van der Schouw Y.T., Grobbee D.E., de Leeuw P.W., Bots M.L. Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analyses. Vasc. Health Risk Manag. 2008, 4:427-436.
28. Zhang A., Zhang M., Zhang J., Yu Y., Xie J. The influence of the Pro12Ala mutation of PPARgamma2 receptor gene on beta-cells restoration and insulin resistance in type 2 diabetes with hypertension. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2005, 25:648-650.
29. Zhang A., Zhang M.X., Zhang J.H., Xie J.H., Yu Y.K. The influence of the Pro12Ala mutation of PPARγ2 receptor gene clinical character in metabolic syndrome. J. Clin. Intern. Med. 2005, 22:694-696. (Article in Chinese).